Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBITDA Margin (2020 - 2025)

iSpecimen has reported EBITDA Margin over the past 6 years, most recently at 9662.19% for Q4 2025.

  • Quarterly results put EBITDA Margin at 9662.19% for Q4 2025, down 925238.0% from a year ago — trailing twelve months through Dec 2025 was 543.68% (down 40916.0% YoY), and the annual figure for FY2025 was 543.68%, down 40916.0%.
  • EBITDA Margin for Q4 2025 was 9662.19% at iSpecimen, down from 2608.68% in the prior quarter.
  • Over the last five years, EBITDA Margin for ISPC hit a ceiling of 31.81% in Q1 2021 and a floor of 9662.19% in Q4 2025.
  • Median EBITDA Margin over the past 5 years was 102.08% (2022), compared with a mean of 717.38%.
  • Biggest five-year swings in EBITDA Margin: surged 14552bps in 2024 and later tumbled -925238bps in 2025.
  • iSpecimen's EBITDA Margin stood at 78.26% in 2021, then grew by 8bps to 72.31% in 2022, then tumbled by -54bps to 111.49% in 2023, then tumbled by -268bps to 409.81% in 2024, then plummeted by -2258bps to 9662.19% in 2025.
  • The last three reported values for EBITDA Margin were 9662.19% (Q4 2025), 2608.68% (Q3 2025), and 146.85% (Q2 2025) per Business Quant data.